⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11332910 | 0.73 | — | — | |
| Formaldehyde SCHEMBL28328963 | 0.70 | — | — | |
| Hydrazinecarboxamide SCHEMBL1864580 | 0.70 | — | — | |
| Hydrazinecarboxamide SCHEMBL27840683 | 0.70 | — | — | |
| Hydrazinecarboxamide SCHEMBL10889812 | 0.70 | TSHR (0.83) | — | |
| Hydrazinecarboxamide SCHEMBL28812032 | 0.67 | TSHR (0.77) | — | |
| Hydrazinecarboxamide SCHEMBL15393 | 0.67 | — | — | |
| SCHEMBL325517 | 0.67 | — | — | |
| SCHEMBL7258925 | 0.67 | TSHR (0.54) | — | |
| SCHEMBL20178517 | 0.67 | NFKB1 (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 17866 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238282-A1 | METHODS OF TREATING CANCER AND ISCHEMIA DISEASES BY INHIBITION AND INTERVENTION OF ATR PROLYL ISOMERIZATION | THE UNIVERSITY OF TOLEDO (US) | 2024-07-18 | — | — | US | claimed |
| US-20240216401-A1 | COMBINATION THERAPY BY USING AKR1C3-ACTIVATED COMPOUND WITH IMMUNE CHECKPOINT INHIBITOR | OBI PHARMA, INC. (TW) | 2024-07-04 | — | — | US | claimed |
| US-20240207433-A1 | DRUG CONJUGATES CONTAINING ALPHA-ENOLASE ANTIBODIES AND USES THEREOF | HUNILIFE BIOTECHNOLOGY, INC. (TW) | 2024-06-27 | — | — | US | claimed |
| US-11998584-B2 | Conjugate of a tubulysin analog with branched linkers | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2024-06-04 | — | — | US | claimed |
| US-11975076-B2 | Antibody-drug conjugates comprising branched linkers and methods related thereto | LEGOCHEM BIOSCIENCES, INC. (KR) | 2024-05-07 | — | — | US | claimed |
| US-20240131178-A1 | ANTIBODY-DRUG CONJUGATE INCLUDING ANTIBODY AGAINST HUMAN CLDN18.2, AND USE THEREOF | LEGOCHEM BIOSCIENCES, INC. (KR) | 2024-04-25 | — | — | US | claimed |
| EP-3380124-B1 | CONJUGATES COMPRISING SELF-IMMOLATIVE GROUPS AND METHODS RELATED THERETO | LEGOCHEM BIOSCIENCES INC (KR) | 2024-04-03 | — | — | EP | claimed |
| CN-117729917-A | Combination therapy using AKR1C3 activating compounds and immune checkpoint inhibitors | 深圳艾欣达伟医药科技有限公司 | 2024-03-19 | — | — | CN | claimed |
| EP-4329745-A1 | COMBINATION THERAPY BY USING AKR1C3-ACTIVATED COMPOUND WITH IMMUNE CHECKPOINT INHIBITOR | OBI PHARMA, INC. (TW) | 2024-03-06 | — | — | EP | claimed |
| EP-4321180-A1 | ANTIBODY-DRUG CONJUGATE INCLUDING ANTIBODY AGAINST HUMAN CLDN18.2, AND USE THEREOF | LegoChem Biosciences, Inc. (KR) | 2024-02-14 | — | — | EP | claimed |
| EP-1024799-A1 | METHOD FOR TREATING DISEASE-RELATED OR DRUG-INDUCED DYSKINESIAS | WARNER-LAMBERT COMPANY (US) | 2000-08-09 | — | — | EP | claimed |
| WO-2000009131-A1 | DIAMINOPYRIMIDINES AND COMBINATION THERAPIES EFFECTIVE FOR TREATMENT OF P-GLYCOPROTEIN POSITIVE CANCERS | WARNER-LAMBERT COMPANY (US) | 2000-02-24 | — | — | WO | claimed |
| WO-2000000197-A1 | 4-BENZYL PIPERIDINE ALKYLSULFOXIDE HETEROCYCLES AND THEIR USE AS SUBTYPE-SELECTIVE NMDA RECEPTOR ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 2000-01-06 | — | — | WO | claimed |
| EP-0869792-A4 | 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS | WARNER LAMBERT CO (US) | 1999-09-22 | — | — | EP | claimed |
| WO-1999021539-A1 | METHOD FOR TREATING DISEASE-RELATED OR DRUG-INDUCED DYSKINESIAS | WARNER-LAMBERT COMPANY (US) | 1999-05-06 | — | — | WO | claimed |
| EP-0869792-A2 | 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 1998-10-14 | — | — | EP | claimed |
| WO-1997023216-A1 | 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 1997-07-03 | — | — | WO | claimed |
| EP-0282547-A4 | METHOD FOR CONTROLLING EMESIS CAUSED BY CHEMOTHERAPEUTIC AGENTS AND ANTIEMETIC AGENTS USEFUL THEREIN | — | 1990-11-28 | — | — | EP | claimed |
| EP-0282547-A1 | METHOD FOR CONTROLLING EMESIS CAUSED BY CHEMOTHERAPEUTIC AGENTS AND ANTIEMETIC AGENTS USEFUL THEREIN. | ADRIA LAB INC (US) | 1988-09-21 | — | — | EP | claimed |
| WO-1988001866-A1 | METHOD FOR CONTROLLING EMESIS CAUSED BY CHEMOTHERAPEUTIC AGENTS AND ANTIEMETIC AGENTS USEFUL THEREIN | ADRIA LABORATORIES, INC. (US) | 1988-03-24 | — | — | WO | claimed |